PDS01ADC trials for Prostate cancer

All PDS01ADC trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying PDS01ADC for Prostate cancer

• A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
  NCT04633252 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 110 Years · Sex: Male · 1 location
• A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
  NCT05361798 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
  NCT06096870 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: Male · 1 location

Common questions

How many trials study PDS01ADC for Prostate cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.